Delivery Order SPE2DB22D1017-SPE2DB25FE8EN

Award Date 10/30/24
Potential Completion Date 10/31/24
Potential Value $6.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $10,960.98, is for the delivery of NAFTIN 1% GEL 40GM, a pharmaceutical product, with a completion date of November 28, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,736.50 firm fixed-price delivery order is for the supply of NAFTIN 2% GEL 45GM, a medical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,304.50 firm-fixed-price delivery order is for the provision of NAFTIN 1% GEL 60GM, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2023. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,146.45 fixed-price delivery order is for the product NAFTIN 2% GEL 45GM, with a completion date of June 11, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support...
This contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) is for the supply of NAFTIN 2% Gel, a prescription pharmaceutical product, with a ceiling value of $2,583.70. The contract is a Delivery Order with a firm fixed-price pricing structure and an ultimate completion date of August 12, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract to provide the specified medication to support the healthcare needs of military...
This federal contract award, SPE2DB24D1034|SPE2DB25FVYK7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,997.11 firm-fixed-price delivery order is for the supply of NAFTIN 2% GEL 45GM, a medical product, with a completion date of November 12, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,063.48 delivery order is for the supply of NAFTIN 1% GEL 60GM, with an ultimate completion date of October 23, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $1,054.98, is for the delivery of the drug product NAFTIN 1% GEL 40GM. It is a firm fixed-price delivery order contract with an ultimate completion date of April 19, 2024. AmerisourceBergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, holds a significant...
This federal contract award, valued at $5,108.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4563323990 - NAFTIN 1% GEL 40GM, a pharmaceutical product. The award has an ultimate completion date of January 16, 2024 and a firm fixed-price pricing type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,211.25 firm-fixed-price delivery order is for the supply of NAFTIN 2% GEL 45GM, a pharmaceutical product, with a completion date of January 12, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FE8EN
    Delivery Order

This federal contract award, valued at $6,094.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of NAFTIN 2% Gel, a pharmaceutical product, with an ultimate completion date of October 31, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 5/20/25, 2:27 PM